Keflex (Cefalexin Monohydrate)

Cefalexin belongs to the cephalosporin class and works by binding to penicillin‑binding proteins on bacterial cell walls. This inhibits the cross‑linking of peptidoglycan strands, weakening the wall and causing bacterial cell lysis. The result is rapid bacterial death, especially in organisms that are sensitive to this mechanism.

The prescribed dose of Keflex is individualized by the treating clinician based on the type and severity of infection, the patient’s age, weight, and renal function. Dosage adjustments may be required for children or patients with impaired kidney function to ensure safety and efficacy.

Safety data for Keflex in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers will evaluate the individual situation and advise whether treatment is appropriate.

To order Keflex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Keflex (cefexin) is a first‑generation cephalosporin, offering a broader spectrum against certain Gram‑positive bacteria and better stability against beta‑lactamase enzymes compared with amoxicillin, a penicillin derivative. Choice of therapy depends on the infection type, bacterial susceptibility, patient tolerance, and local resistance patterns.

Keflex should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product in a dry, cool place helps maintain its potency throughout the shelf life.

Keflex is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce stomach upset in some patients. The exact administration schedule is determined by the prescribing clinician.

Serious adverse reactions include anaphylaxis (severe allergic response), Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, serum sickness, hemolytic anemia, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms such as rash, difficulty breathing, persistent diarrhea, or jaundice.

Keflex should be avoided by individuals with a known hypersensitivity to cefalexin, other cephalosporins, or penicillins. Patients with severe renal impairment may require dose adjustment or alternative therapy. Anyone with a history of severe allergic reactions to beta‑lactam antibiotics should not take Keflex without medical supervision.